SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-136788
Filing Date
2024-05-13
Accepted
2024-05-13 09:15:59
Documents
15
Period of Report
2024-05-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d818591d8k.htm   iXBRL 8-K 29839
2 EX-99.1 d818591dex991.htm EX-99.1 15621
  Complete submission text file 0001193125-24-136788.txt   233654

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA blacu-20240513.xsd EX-101.SCH 4877
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blacu-20240513_def.xml EX-101.DEF 15321
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE blacu-20240513_lab.xml EX-101.LAB 26119
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blacu-20240513_pre.xml EX-101.PRE 16485
18 EXTRACTED XBRL INSTANCE DOCUMENT d818591d8k_htm.xml XML 9114
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)

IRS No.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41390 | Film No.: 24937142
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)